Full text is available at the source.
Abstract
GLP-1 receptor agonists (GLP-1 RAs) may shift microglia to a protective anti-inflammatory state.
- Microglia are immune cells in the central nervous system that can adopt pro-inflammatory (M1) or anti-inflammatory (M2) states.
- The M1 state is associated with neurotoxicity, while the M2 state contributes to tissue repair.
- Activation of microglia plays a role in neuroinflammation and pain sensitivity in neurodegenerative disorders like Parkinson's and Alzheimer's diseases.
- GLP-1 RAs can bind to receptors on microglia, promoting a shift towards the anti-inflammatory M2 phenotype.
- Preclinical models indicate that GLP-1 RAs may reduce pain hypersensitivity, enhance cognitive function, and diminish inflammatory responses.
- These findings suggest that GLP-1 RAs could be a viable treatment for chronic pain and neurodegenerative diseases through their effects on microglial activity.
Simplified